Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach-Reference-Cited by-同舟云学术

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach

Published:2013-11-12 Issue:11 Volume:8 Page:e78544
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bittoni Alessandro,Scartozzi Mario,Giampieri Riccardo,Faloppi Luca,Bianconi Maristella,Mandolesi Alessandra,Prete Michela Del,Pistelli Mirco,Cecchini Luca,Bearzi Italo,Cascinu Stefano

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference19 articles.

1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

2. Helicobacter pylori and gastrointestinal tract adenocarcinomas;RMJ Peek;Nat Rev Cancer,2002

3. Precancerous gastric lesions in a population at high risk of stomach cancer;WC You;Cancer Res,1993

4. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and it's implications for patient screening;F Carneiro;J Pathol,2004

5. Different patterns of recurrence in gastric cancer depending on Lauren's histologic type: longitudinal study;D Marrelli;World J Surg,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy;Cancers;2023-06-25

2. Current and future strategies for radiation therapy in gastric cancer;Journal of Surgical Oncology;2022-04-28

3. E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib;Cancers;2022-03-22

4. An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer;Oncology Letters;2021-02-09

5. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer;Therapeutic Advances in Medical Oncology;2020-01